Jan 17, 2026
Do regulatory bodies re-analyse pharmaceutical data regarding new drug products
Regulators do more than rubber‑stamp sponsor analyses: they critically review, challenge, and sometimes re‑analyse datasets and models submitted for new drug approvals, and they continue to scrutinize...